All
Search
Images
Videos
Maps
News
Copilot
More
Shopping
Flights
Travel
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Order by
Best match
Most fresh
Past 30 days
Any time
Past hour
Past 24 hours
Past 7 days
Cancer Research
28d
TUB-010, a Novel Anti-CD30 Antibody–Drug Conjugate Based on Tub-Tag Technology, Widens the Therapeutic Window by Reducing Toxicity While Maintaining High Efficacy
1Tubulis GmbH, Planegg-Martinsried, Germany.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Trump reverses course
FSIS issues health alert
Reveals cancer diagnosis
Bob Power dies
Volunteers to testify
Top aides resigning
'Deadliest Catch' star dies
Today in history: 2018
Orders hospital to resume care
Release date moved up
To impose visa restrictions
Announces NFL retirement
4 troops killed in war ID'd
Trump threatens Spain
Ex-NASCAR driver dies at 42
Colin Gray found guilty
Musk to face Twitter trial
Pulled into GOP runoff
Profar faces 162-game ban?
US closes 2 Gulf embassies
Pitt fires coach Verdi
Warns 30 telehealth firms
Kentucky AD to retire
Facebook suffers outage
To compete in NC Senate race
Defeated by Steve Toth
Intel board chair to exit
US, Ecuador drug crackdown
UAE: Fire at Fujairah oil hub
Credit ratings cut by Fitch
World Cup faces turmoil
To settle patent cases
Feedback
